Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease
暂无分享,去创建一个
H. Fuchs | M. Angelis | K. Schramm | M. Tschöp | M. Heikenwalder | C. Weber | H. Biebermann | V. Gailus-Durner | R. DiMarchi | J. Köhrle | F. Neff | J. Tuckermann | V. Gelfanov | T. Müller | Y. Döring | M. Jastroch | J. Rozman | D. Perez-Tilve | K. Habegger | M. A. Sánchez-Garrido | P. Liu | C. Clemmensen | K. Moreth | M. E. Healy | M. Keuper | S. Hofmann | K. Fischer | B. Finan | K. Stemmer | A. Weber | K. Gauthier | Bin Yang | F. Flamant | M. Kleinert | D. Lutter | S. Jall | S. Brandt | M. Malehmir | Zhimeng Zhu | M. D. Angelis | Luisa Müller | Faming Liu | M. Healy | Peng Liu | Sigrid Jall | Brian Finan
[1] Jeffrey R. Chabot,et al. A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects. , 2016, Cell metabolism.
[2] Sean M. Hartig,et al. Pharmacological Activation of Thyroid Hormone Receptors Elicits a Functional Conversion of White to Brown Fat. , 2015, Cell reports.
[3] Y. Wan,et al. A Liver-Bone Endocrine Relay by IGFBP1 Promotes Osteoclastogenesis and Mediates FGF21-Induced Bone Resorption. , 2015, Cell metabolism.
[4] R. Gimeno,et al. Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1. , 2015, Cell reports.
[5] R. DiMarchi,et al. Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis , 2015, Scientific Reports.
[6] M. Véniant,et al. Pharmacologic Effects of FGF21 Are Independent of the "Browning" of White Adipose Tissue. , 2015, Cell metabolism.
[7] D. Diamond,et al. How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease , 2015, Expert review of clinical pharmacology.
[8] M. Tschöp,et al. GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice , 2014, Diabetologia.
[9] R. Seeley,et al. A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents , 2014, Nature Medicine.
[10] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[11] H. Moch,et al. Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. , 2014, Cancer cell.
[12] B. Singh,et al. Thyroid hormone regulation of hepatic lipid and carbohydrate metabolism , 2014, Trends in Endocrinology & Metabolism.
[13] P. Ladenson,et al. Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study. , 2014, The lancet. Diabetes & endocrinology.
[14] S. Fleury,et al. TRα protects against atherosclerosis in male mice: identification of a novel anti-inflammatory property for TRα in mice. , 2014, Endocrinology.
[15] S. So,et al. Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β agonist in clinical trials for the treatment of dyslipidemia. , 2014, Journal of medicinal chemistry.
[16] G. Brent,et al. Thyroid hormone regulation of metabolism. , 2014, Physiological reviews.
[17] J. Flier,et al. Fibroblast growth factor 21 and thyroid hormone show mutual regulatory dependency but have independent actions in vivo. , 2014, Endocrinology.
[18] J. Allard,et al. Clinical approaches to non-alcoholic fatty liver disease. , 2014, World journal of gastroenterology.
[19] J. Samarut,et al. The targeted inactivation of TRβ gene in thyroid follicular cells suggests a new mechanism of regulation of thyroid hormone production. , 2014, Endocrinology.
[20] A. Adams,et al. Inventing new medicines: The FGF21 story☆ , 2013, Molecular metabolism.
[21] G. Shulman,et al. Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler. , 2013, Cell metabolism.
[22] Bin Yang,et al. Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans , 2013, Science Translational Medicine.
[23] J. Tardif,et al. Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonist. , 2013, Atherosclerosis.
[24] H. Fu,et al. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. , 2013, Cell metabolism.
[25] F. Villarroya,et al. Fibroblast growth factor 21 protects against cardiac hypertrophy in mice , 2013, Nature Communications.
[26] S. Woods,et al. Fibroblast Growth Factor 21 Mediates Specific Glucagon Actions , 2013, Diabetes.
[27] Bin Yang,et al. Targeted estrogen delivery reverses the metabolic syndrome , 2012, Nature Medicine.
[28] W. Hsueh,et al. Thyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptor. , 2012, Endocrinology.
[29] B. Bay,et al. Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy. , 2012, The Journal of clinical investigation.
[30] S. Kliewer,et al. Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ , 2012, Proceedings of the National Academy of Sciences.
[31] Peter Libby,et al. Effect of two intensive statin regimens on progression of coronary disease. , 2011, The New England journal of medicine.
[32] B. Spiegelman,et al. Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo. , 2011, Endocrinology.
[33] M. Tschöp,et al. The metabolic actions of glucagon revisited , 2010, Nature Reviews Endocrinology.
[34] P. Ladenson,et al. Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study. , 2010, The Journal of clinical endocrinology and metabolism.
[35] S. Woods,et al. A new glucagon and GLP-1 co-agonist eliminates obesity in rodents. , 2009, Nature chemical biology.
[36] M. Konishi,et al. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. , 2009, Endocrinology.
[37] J. Baxter,et al. Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes , 2009, Nature Reviews Drug Discovery.
[38] D. Bauer,et al. Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality , 2008, Annals of Internal Medicine.
[39] J. E. Silva,et al. Thermogenic mechanisms and their hormonal regulation. , 2006, Physiological reviews.
[40] D. Kelly,et al. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. , 2006, The Journal of clinical investigation.
[41] Christoph Handschin,et al. Metabolic control through the PGC-1 family of transcription coactivators. , 2005, Cell metabolism.
[42] Waljit S Dhillo,et al. Triiodothyronine stimulates food intake via the hypothalamic ventromedial nucleus independent of changes in energy expenditure. , 2004, Endocrinology.
[43] Johan Malm,et al. Selective thyroid hormone receptor-β activation: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[44] Marc Montminy,et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 , 2001, Nature.
[45] R J Fletterick,et al. Hormone selectivity in thyroid hormone receptors. , 2001, Molecular endocrinology.
[46] C. Kellendonk,et al. Hepatocyte‐specific expression of Cre recombinase , 2000, Genesis.
[47] B. Cannon,et al. Apparent thermogenic effect of injected glucagon is not due to a direct effect on brown fat cells. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[48] R. Burcelin,et al. Cloning and sequence analysis of the murine glucagon receptor-encoding gene. , 1995, Gene.
[49] A. Levine,et al. Glucagon in physiological concentrations stimulates brown fat thermogenesis in vivo. , 1991, The American journal of physiology.
[50] M. Obregon,et al. Effects of maternal hypothyroidism on the weight and thyroid hormone content of rat embryonic tissues, before and after onset of fetal thyroid function. , 1985, Endocrinology.
[51] M. Reitman,et al. Effect of Glucagon on the Metabolism of Lipids and on Urea Formation by the Perfused Rat Liver , 1966, Diabetes.
[52] A. Bianco,et al. Intracellular conversion of thyroxine to triiodothyronine is required for the optimal thermogenic function of brown adipose tissue. , 1987, The Journal of clinical investigation.